The Centers for Disease Control and Prevention has reinforced its commitment to making STI testing and treatment more accessible across the United States. This matters because the barrier between knowing your status and getting care quickly can mean the difference between preventing transmission and spreading infection to partners.
According to the CDC, expanding availability of testing and treatment products is a core public health priority. The agency recognizes that men aged 25 to 45 who are sexually active need fast, discreet pathways to both diagnosis and prevention tools. This aligns with the CDC's 2024 guidance on post-exposure prophylaxis and routine STI screening for at-risk populations.
For sexually active men, this means your options for prevention and treatment are growing. If you've had potential exposure to an STI, post-exposure prophylaxis like doxycycline taken within 72 hours can significantly reduce your risk. If you're diagnosed with an infection, treatment should start immediately. At B Brand, we make accessing DoxyPEP, STI testing referrals, and treatment straightforward and discreet, with prescriptions written same-week and shipped to most US states.
Featured Products
Stay current on men's sexual health.
New articles, research updates, and treatment guides delivered to your inbox.
No spam. Unsubscribe anytime.
